PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33030957-4 2021 Inhibition of MEK/ERK by cobimetinib or CDK inhibitor dinaciclib was shown to attenuate mutant BRAF-induced PD-L1 coincident with reduced c-JUN and YAP expression whose combined knockdown reduced PD-L1. dinaciclib 54-64 mitogen-activated protein kinase 1 Homo sapiens 18-21 27469405-4 2016 Moreover, treatment with dinaciclib led to the inhibition of oncogenic pathways normally activated in stimulated CLL cells, such as STAT3, NF-kappaB, p38, PI3K/AKT and RAF/MEK/ERK. dinaciclib 25-35 mitogen-activated protein kinase 1 Homo sapiens 176-179